These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38550122)
41. [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039879 [TBL] [Abstract][Full Text] [Related]
42. miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1/CEP55. Pengjie Y; Rong J; Pengfei N Sci Rep; 2024 Jan; 14(1):305. PubMed ID: 38172247 [TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420 [TBL] [Abstract][Full Text] [Related]
44. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment. International BR Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366 [TBL] [Abstract][Full Text] [Related]
45. Retracted: circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway. Markers D Dis Markers; 2023; 2023():9757632. PubMed ID: 37564088 [TBL] [Abstract][Full Text] [Related]
46. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach. Markers D Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889 [TBL] [Abstract][Full Text] [Related]
47. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma. Longevity OMAC Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171 [TBL] [Abstract][Full Text] [Related]
48. Retracted: Expression Level and Clinical Significance of AK021443 in Non-Small-Cell Lung Carcinoma. Healthcare Engineering JO J Healthc Eng; 2023; 2023():9830874. PubMed ID: 37829415 [TBL] [Abstract][Full Text] [Related]
49. [Retracted] Knockdown of circ_0001883 may inhibit epithelial‑mesenchymal transition in laryngeal squamous cell carcinoma via the miR‑125‑5p/PI3K/AKT axis. Chen F; Lao Z; Zhang H; Wang J; Wang S Exp Ther Med; 2024 Apr; 27(4):129. PubMed ID: 38414792 [TBL] [Abstract][Full Text] [Related]
50. [Retracted] Long non‑coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA‑204‑5p/SEMA4B axis. Han L; Zheng C; Wu S Oncol Lett; 2024 Jan; 27(1):15. PubMed ID: 38028178 [TBL] [Abstract][Full Text] [Related]
51. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway. Liu B; Cao G; Dong Z; Guo T Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102 [TBL] [Abstract][Full Text] [Related]
52. Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9847941. PubMed ID: 37811260 [TBL] [Abstract][Full Text] [Related]
53. Retracted: Diagnostic Value of MRI Combined with CXCR4 Expression Level in Lymph Node Metastasis Head and Neck Squamous Cell Carcinoma. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9754632. PubMed ID: 37538469 [TBL] [Abstract][Full Text] [Related]
54. Retracted: MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9876019. PubMed ID: 37475907 [TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis. Hao J; Li M; Zhang T; Yu H; Liu Y; Xue Y; An R; Wang S Front Oncol; 2020; 10():614. PubMed ID: 32411602 [No Abstract] [Full Text] [Related]
56. Retracted: Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach. International BR Biomed Res Int; 2024; 2024():9878069. PubMed ID: 38230060 [TBL] [Abstract][Full Text] [Related]
57. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma. And Alternative Medicine EC Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232 [TBL] [Abstract][Full Text] [Related]
58. RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. Wang Y; Xie Z; Lu H Life Sci; 2020 Sep; 257():118104. PubMed ID: 32679143 [TBL] [Abstract][Full Text] [Related]
59. Retracted: The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma. Methods In Medicine CAM Comput Math Methods Med; 2022; 2022():9897274. PubMed ID: 36534039 [TBL] [Abstract][Full Text] [Related]
60. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Baba Y; Nomoto D; Okadome K; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H Cancer Sci; 2020 Sep; 111(9):3132-3141. PubMed ID: 32579769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]